» Articles » PMID: 21416196

Diagnosis of Tetrahydrobiopterin Deficiency Using Filter Paper Blood Spots: Further Development of the Method and 5 Years Experience

Overview
Publisher Wiley
Date 2011 Mar 19
PMID 21416196
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

In every newborn with even mild hyperphenylalaninemia (HPA) tetrahydrobiopterin (BH(4)) deficiencies need to be excluded as soon as possible. Differential diagnosis is most commonly performed by analysis of urinary neopterin and biopterin. In 2005 a new method for the measurement of neopterin, biopterin and other pterins in dried blood spot (DBS) on filter paper was introduced. In order to evaluate the usefulness of this method as a standard tool for differential diagnosis of HPAs we analyzed neopterin, biopterin, pterin and dihydropteridine reductase activity in DBS from 362 patients with HPA over the period of five years. Age-dependent reference values were established for the HPA population. Sixty-four patients with BH(4) deficiency (27 patients with 6-pyruvoyl-tetrahydropterin synthase deficiency, seven with GTP cyclohydrolase I deficiency, and 30 with dihydropteridine reductase) were identified. Reference values for neopterin and biopterin in DBS were calculated for each of the variants. 6-pyruvoyl-tetrahydropterin synthase and GTP cyclohydrolase I deficiency can be diagnosed by neopterin and biopterin analysis alone, while for diagnosis of dihydropteridine reductase deficiency additional determination of enzyme activity from the same DBS is essential. Regarding test sensitivity, the interpretation of neopterin and biopterin concentration per hemoglobin is more valid than the interpretation of neopterin and biopterin per liter. Percentage of biopterin, of the sum of neopterin and biopterin should always be calculated. In addition, determination of hemoglobin concentration is essential as a measure for efficient extraction of neopterin and biopterin. Although the measurement of neopterin and biopterin in urine is more sensitive due to the higher concentrations present, our data prove the usefulness of their measurement from DBS for the routine diagnosis of BH(4) deficiencies.

Citing Articles

Fast Label-Free Metabolic Profile Recognition Identifies Phenylketonuria and Subtypes.

Su H, Zhang H, Wu J, Huang L, Zhang M, Xu W Adv Sci (Weinh). 2024; 11(15):e2305701.

PMID: 38348590 PMC: 11022714. DOI: 10.1002/advs.202305701.


Systems Biology and Inborn Error of Metabolism: Analytical Strategy in Investigating Different Biochemical/Genetic Parameters.

Piombarolo A, Ialongo C, Bizzarri M, Angeloni A Methods Mol Biol. 2023; 2745:191-210.

PMID: 38060187 DOI: 10.1007/978-1-0716-3577-3_12.


Mutation spectrum of gene in patients with tetrahydrobiopterin deficiency from jiangxi province.

Xie K, Zeng B, Zhang L, Chen S, Zou Y, Yuan H Front Genet. 2022; 13:1077729.

PMID: 36583021 PMC: 9792861. DOI: 10.3389/fgene.2022.1077729.


Genotypic spectrum underlying tetrahydrobiopterin metabolism defects: Experience in a single Mexican reference center.

Vela-Amieva M, Alcantara-Ortigoza M, Ibarra-Gonzalez I, Gonzalez-Del Angel A, Fernandez-Hernandez L, Guillen-Lopez S Front Genet. 2022; 13:993612.

PMID: 36313470 PMC: 9597361. DOI: 10.3389/fgene.2022.993612.


Sapropterin dihydrochloride therapy in dihydropteridine reductase deficiency: Insight from the first case with molecular diagnosis in Brazil.

Lourenco C, Dovidio J, Lopes I, Silva L, Almeida M, Vagnini L JIMD Rep. 2021; 61(1):19-24.

PMID: 34485013 PMC: 8411105. DOI: 10.1002/jmd2.12224.


References
1.
Zorzi G, Thony B, Blau N . Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency. J Neurochem. 2002; 80(2):362-4. DOI: 10.1046/j.0022-3042.2001.00710.x. View

2.
Arai N, Narisawa K, Hayakawa H, Tada K . Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots. Pediatrics. 1982; 70(3):426-30. View

3.
Ponzone A, Guardamagna O, Spada M, Ponzone R, Sartore M, Kierat L . Hyperphenylalaninemia and pterin metabolism in serum and erythrocytes. Clin Chim Acta. 1993; 216(1-2):63-71. DOI: 10.1016/0009-8981(93)90139-u. View

4.
Dale R, Brilot F, Fagan E, Earl J . Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol. 2009; 51(4):317-23. DOI: 10.1111/j.1469-8749.2008.03225.x. View

5.
Murr C, Widner B, Wirleitner B, Fuchs D . Neopterin as a marker for immune system activation. Curr Drug Metab. 2002; 3(2):175-87. DOI: 10.2174/1389200024605082. View